Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Operating Expenses (2020 - 2023)

Historic Other Operating Expenses for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to $13.9 million.

  • ADC Therapeutics' Other Operating Expenses rose 17682.73% to $13.9 million in Q3 2023 from the same period last year, while for Dec 2023 it was $3.7 billion, marking a year-over-year decrease of 6059.35%. This contributed to the annual value of $4.8 billion for FY2022, which is N/A changed from last year.
  • Per ADC Therapeutics' latest filing, its Other Operating Expenses stood at $13.9 million for Q3 2023, which was up 17682.73% from $15.6 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year Other Operating Expenses high stood at $4.9 billion for Q1 2022, and its period low was -$73.4 million during Q1 2020.
  • Its 4-year average for Other Operating Expenses is $1.0 billion, with a median of -$16665.0 in 2022.
  • Per our database at Business Quant, ADC Therapeutics' Other Operating Expenses crashed by 28316.68% in 2021 and then surged by 3502892.67% in 2022.
  • ADC Therapeutics' Other Operating Expenses (Quarter) stood at -$6.1 million in 2020, then surged by 973.06% to $53.4 million in 2021, then tumbled by 100.03% to -$16665.0 in 2022, then skyrocketed by 83736.36% to $13.9 million in 2023.
  • Its Other Operating Expenses stands at $13.9 million for Q3 2023, versus $15.6 million for Q2 2023 and $3.7 billion for Q1 2023.